Ken Griffin Lantheus Holdings, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$77.7 - $123.62 $3.35 Million - $5.33 Million	-43,100 Reduced 23.12%	143,300 $15.7 Million
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $12 Million - $16.9 Million	-203,100 Reduced 52.14%	186,400 $15 Million
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $7.56 Million - $10.1 Million	148,100 Added 61.35%	389,500 $24.2 Million
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $6.49 Million - $9.1 Million	116,800 Added 93.74%	241,400 $15 Million
Q3 2023 Nov 14, 2023	SELL	$60.27 - $90.75 $1.68 Million - $2.52 Million	-27,800 Reduced 18.24%	124,600 $8.66 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $4.01 Million - $4.84 Million	48,600 Added 46.82%	152,400 $12.8 Million
Q1 2023 May 15, 2023	SELL	$47.76 - $82.86 $573,120 - $994,320	-12,000 Reduced 10.36%	103,800 $8.57 Million
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $6.01 Million - $9.57 Million	-123,200 Reduced 51.55%	115,800 $5.9 Million
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $5.69 Million - $7.99 Million	92,600 Added 63.25%	239,000 $16.8 Million

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.15B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.